Incannex expands IHL-675A indications to include COPD, asthma, bronchitis, and other inflammatory lung conditions – after receiving positive results from additional in vivo studies Feb 4, 2021 ASX News Incannex Healthcare (ASX:IHL) Send Share Share
HARVEST INFINITY PLATFORM EXPANDED TO INCLUDE DRONES Jul 22, 2020 | ASX News, Harvest Technology Group (ASX:HTG)
Nyrada Inc: Change of Registered Office and Principal Place of Business Apr 26, 2021 | ASX News, Nyrada Inc (ASX:NYR)
Incannex Psi-GAD clinical development overview Aug 13, 2021 | ASX News, Incannex Healthcare (ASX:IHL)